Augmentation of myocardial If dysregulates calcium homeostasis and causes adverse cardiac remodeling

Abstract

HCN channels underlie the depolarizing funny current (If) that contributes importantly to cardiac pacemaking. If is upregulated in failing and infarcted hearts, but its implication in disease mechanisms remained unresolved. We generated transgenic mice (HCN4tg/wt) to assess functional consequences of HCN4 overexpression-mediated If increase in cardiomyocytes to levels observed in human heart failure. HCN4tg/wt animals exhibit a dilated cardiomyopathy phenotype with increased cellular arrhythmogenicity but unchanged heart rate and conduction parameters. If augmentation induces a diastolic Na+ influx shifting the Na+/Ca2+ exchanger equilibrium towards ‘reverse mode’ leading to increased [Ca2+]i. Changed Ca2+ homeostasis results in significantly higher systolic [Ca2+]i transients and stimulates apoptosis. Pharmacological inhibition of If prevents the rise of [Ca2+]i and protects from ventricular remodeling. Here we report that augmented myocardial If alters intracellular Ca2+ homeostasis leading to structural cardiac changes and increased arrhythmogenicity. Inhibition of myocardial If per se may constitute a therapeutic mechanism to prevent cardiomyopathy.

Introduction

The hyperpolarization-activated cyclic nucleotide-gated channel 4 (HCN4) is the dominant HCN-isoform in the sinoatrial node and is significantly involved in generation and regulation of heart rhythm1,2,3,4. Apart from its abundant expression in the pacemaker and conduction system, the adult working myocardium is characterized by low HCN levels5,6. At early embryonic stages, however, HCN4 is abundantly transcribed in the whole heart6 and contributes importantly to If triggered automaticity of ventricular myocytes7. Moreover, HCN4 was identified as a cell marker for the cardiomyogenic progenitor pool of the first heart field, implicated in the earliest stage of cardiac mesoderm formation and morphogenesis8,9,10. Toward birth HCN4 transcription is downregulated in working-type cardiomyocytes6 and remains at low levels during adult stages, suggested to prevent pathological remodeling6. In this context, increased If and HCN expression was reported in failing hearts and after myocardial infarction5,11,12, but its pathophysiological role remains to be established. Notably, pharmacological blockade of If improves cardiovascular outcome in patients with chronic heart failure—results that were considered to be driven mainly by improved myocardial energy supply at lower heart rates13,14. However, recent data demonstrated that If blockade in patients with coronary artery disease with preserved myocardial function did not improve outcome despite marked reduction of heart rate15, pointing towards mechanisms of If blockade that may be particularly beneficial in failing hearts. In this regard, pleiotropic effects of If blockade beyond heart rate reduction have been suggested16,17, but these mechanisms have not been specified yet.

To study the significance of increased If in the working myocardium, we generated transgenic mice that express human HCN4 (hHCN4) under control of the murine cardiac troponin I (cTNI) gene promoter. We here show that a moderate increase of If in cardiac myocytes to levels observed in heart failure leads to cardiac dilation and impaired cardiac function. HCN4 activity essentially is linked to calcium regulation of cardiomyocytes and augmented If results in dysregulated Ca2+ homeostasis driving cell death and cardiac remodeling.

Results

Generation of transgenic mice overexpressing hHCN4

To study the significance of HCN4 channel overexpression-mediated If augmentation in the working myocardium, transgenic mice were generated that express hHCN4 under control of the murine cTNI gene promoter18,19 (Fig. 1a). HCN4tg/wt offspring are born at a mendelian frequency and exhibit no overt cardiac or general abnormalities. HCN4tg/wt mice produce abundant hHCN4 transcripts (Fig. 1b) leading to increased HCN4 protein levels (Fig. 1c). Intense anti-HCN4 staining signals at the plasma membrane of HCN4tg/wt cardiomyocytes (Fig. 1d) indicate efficient trafficking of hHCN4 channels to the cell surface, while wild type tissue yields only little anti-HCN4 signals. Accordingly, patch-clamp recordings showed significantly increased If densities in HCN4tg/wt cardiomyocytes. At physiological resting membrane potentials (RMP) of ventricular cardiomyocytes (~−90 mV) we observed a two–three3-fold higher If density in HCN4tg/wt cardiomyocytes compared to wild type (Fig. 1e, f), recapitulating the magnitude of current increase that was observed in cardiomyocytes of heart failure patients5.

Fig. 1
figure1

Generation and characterization of transgenic HCN4tg/wt mice. a The transgene carries a 4.3 kb promoter fragment of the murine cTnI gene (cTnI) fused to the human HCN4 cDNA and the bovine growth hormone gene poly A signal (BGH-pA). b Profiling of the endogenous murine HCN1 (mHCN1), HCN2 (mHCN2), HCN4 (mHCN4), and transgenic human HCN4 (hHCN4) transcripts in the ventricular myocardium of 2-month-old HCN4tg/wt mice measured by quantitative real-time PCR, (qRT-PCR). Wild type = 1.0 (n = 6 animals; ***P < 0.001; unpaired t-test). c Western blot and quantitative analysis of HCN4 protein in the ventricular myocardium of HCN4tg/wt transgenic and wild type mice, normalized to glyceraldehyde 3-phosphate dehydrogenase (GAPDH) for control of protein loading. For comparison samples with different protein load (10, 20, 30 µg) are shown (n = 6 animals/groups; *P < 0.05, **P < 0.01, ***P < 0.001; unpaired t-test). d Immunohistochemistry for HCN4 (red) in ventricular myocardium of wild type (left) and transgene (right) mice. Scale bars 20 μm. Representative If currents (e) and current-voltage relationship (f) recorded from ventricular cardiomyocytes isolated from HCN4tg/wt and wild type mice (n = 20 cells from six wild type mice and n = 16 cells from five HCN4tg/wt mice; *P < 0.05, **P < 0.01, ***P < 0.001; unpaired t-test). Data are expressed as mean ± s.e.m. Source data are provided as a Source data file

HCN4 tg/wt mice develop structural heart disease

While cardiac morphology was similar at birth, we uncovered cardiac dilation with significantly increased heart-to-body weight ratios in HCN4tg/wt mice 2 months postpartum (Fig. 2a–g). Right ventricular diameters, in particular, were found markedly enlarged (Fig. 2d) and dilation was accompanied with reduced wall thickness (Fig. 2e). To assess cardiac in vivo phenotypes, echocardiographic evaluations were performed at 3 and 6 months of age. At 3-month of age left ventricular wall thickness of HCN4tg/wt mice was lower compared to wild type (Fig. 2l). Similar to the histological findings at 2 months of age there was a trend toward higher left ventricular internal diameters in HCN4tg/wt animals (Fig. 2j, k), although these changes did not reach statistical significance. Fractional area shortening did not differ between groups at this age (Fig. 2i). At 6 month of age, however, HCN4tg/w mice displayed a dilated cardiomyopathy phenotype (Fig. 2h, i) with lower left ventricular wall thickness, dilation of left ventricular internal diameters (Fig. 2n–p) and systolic dysfunction with reduced fractional shortening of 22.9 ± 1.4% compared to 27.5 ± 1.4% in controls (means ± s.e.m., P = 0.031, unpaired t-test) (Fig. 2i). Furthermore mitral valve Doppler imaging displayed increased E/A ratios in transgenic mice indicative for impaired left ventricular relaxation and diastolic dysfunction (2.16 ± 0.22 in HCN4tg/w mice compared to 1.62 ± 0.07 in controls, P = 0.021, unpaired t-test) (Fig. 2m, q).

Fig. 2
figure2

Morphological and functional phenotype of transgenic HCN4tg/wt mice. a Representative HE-stained cryosections display morphology of 2 months-old wild type (left) and HCN4tg/wt (right) hearts showing cardiac dilation and significantly reduced wall thickness in particular of the right ventricle. Scale bar 1 mm. bg HE-stained cryosections illustrating quantitative effects of hHCN4 transgene overexpression on the structural phenotype of hearts in the presence and absence of ivabradine at two month postpartum. Heart-to-body weight ratio (b), cross section of left ventricular cardiomyocytes (c), right ventricle diameter-to-body weight ratio (d), and wall thickness (e), left ventricle diameter-to-body weight ratio (f) and wall thickness (g) of wild type, HCN4tg/wt, and ivabradine-treated HCN4tg/wt mice at 2 months postpartum (n = 6 animals/groups; *P < 0.05, **P < 0.01, ***P < 0.001; ANOVA). hq Transthoracic echocardiography analyses of wild type (left) and HCN4tg/wt mice. The analyses were performed in 3 months- (jm) and 6 months- (nq) old mice. Representative echocardiographic M-mode views in 6 months-old mice (h), and quantification of fractional shortening (FS) (i), left ventricular end-diastolic diameters (LVEDD) (j, n), and volume (LVEDV) (k, o), posterior wall thickness in diastole (LVPW) (l, p) and E/A ratio (m, q) are depicted (3 months-old mice n = 7 wild type and n = 7 transgenic animals/group; 6 months-old mice n = 12 wild type and n = 10 transgenic animals/group; *P < 0.05, **P < 0.01, ***P < 0.001; unpaired t-test). Data are expressed as mean ± s.e.m. Source data are provided as a Source data file

In line with macroscopic alterations in HCN4tg/wt hearts, we observed significantly increased diameters of cardiomyocytes (Fig. 2c) and elongated sarcomeres (Fig. 3a, b). However, HCN4 overexpression did not induce cardiac fibrosis (Fig. 3c, d), and we observed no myocyte disarray or cellular infiltrations (Fig. 3a, e). Early treatment of HCN4tg/wt mice with the If blocker ivabradine significantly reduced chamber dilation and wall rarefication (Fig. 2b–g), and normalized cardiomyocyte diameters (Fig. 2c), indicating that increased If causes the altered structural phenotype.

Fig. 3
figure3

Histological analysis of transgenic HCN4tg/wt hearts. a Electron microscopy analysis of left ventricular sarcomere structure of 2-months-old wild type and HCN4tg/wt hearts. Scale bars: 1250 nm. b Comparative percentile plot of sarcomere lengths’ distribution in cardiomyocytes of wild type (dashed line, n = 480 sarcomeres from six mice) and HCN4tg/wt (solid line, n = 480 sarcomeres from six mice) animals. c Masson’s trichrome staining of right ventricular paraffin sections from wild type and HCN4tg/wt hearts, 2 months postpartum. Scale bars: 100 µm. d Comparative analysis of fibrosis by semi-automatic quantification using ImageJ-based plug-in showed similar levels of fibrosis between wild type (gray column) and HCN4tg/wt (black column) tissue (n = 6 animals/group; *P < 0.05, **P < 0.01, ***P < 0.001; unpaired t-test). e HE staining of right ventricular cryosections from wild type and HCN4tg/wt hearts, 2 months postpartum. Scale bars: 50 µm. Data are expressed as mean ± s.e.m. Source data are provided as a Source data file

Transcriptional alterations in HCN4 tg/wt hearts

We next asked whether structural and functional remodeling in hearts of HCN4tg/wt mice is associated with activation of the fetal gene program. Evaluation of mRNA, isolated from 6-months-old mice, revealed markedly increased levels of the myocardial cell growth markers GSK-3B and mTOR (Fig. 4a) and slightly upregulated levels of the prototypical hypertrophic marker genes MYH7 (encoding ßMHC), CnA (encoding calcineurin A) and NPPA (encoding ANP) (Fig. 4b). We further explored transcriptional profiles of ion channels and transporters, implicated in action potential generation, excitation-contraction coupling and intracellular calcium homeostasis (Fig. 4c, d). Interestingly, HCN4tg/wt hearts displayed significant downregulation of the sodium–calcium exchanger gene NCX1 (Fig. 4c) and intrinsic murine HCN genes were slightly diminished (Fig. 4d). Furthermore, levels of transcripts of the repolarizing channel genes KCNQ1 (encoding Kv7.1) and KCND2 (encoding Kv4.2) were decreased, while the repolarizing channel gene KCNH2 (encoding Kv11.1) showed a trend toward higher levels (Fig. 4e). Other genes regulating calcium handling and cellular electrophysiology, however, showed transcript levels that were not significantly changed.

Fig. 4
figure4

Transcriptional changes and expression of Ca2+ handling proteins in HCN4tg/wt hearts. qPCR and Immunoblots from heart samples of 6 months-old mice. qPCR measurements of gene transcription related to a cell growth, b the fetal gene program and hypertrophy, c Na+/Ca2+-handling, d murine HCN channels, and e cardiac ion channels (6 months-old mice n = 4–8 animals/group). The bars show the transgenic gene expression normalized to wild type expression level = 1.0, which is indicated by the dashed line. *P < 0.05; **P < 0.01; ***P < 0.001 (unpaired t-test). f Representative immunoblots of Ca2+-handling proteins. g Protein expression of transgenic animals compared to wildtype littermates obtained from immunoblots (6 months-old mice n = 3 animals/group). Two replicate immunoblots per animal, in pPln-S16 and pPln-T17 one replicate immunoblot per animal. Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) was used as a loading control. *P < 0.05; **P < 0.01 (unpaired t-test). Data are shown as mean ± s.e.m. Source data are provided as a Source data file

HCN4 overexpression impacts calcium handling proteins

Based on NCX1 downregulation in HCN4tg/wt hearts, we hypothesized that dysregulated intracellular sodium–calcium homeostasis might be a pathomechanistic component in If overexpression-mediated cardiomyopathy. To evaluate a contribution of calcium handling proteins we performed immunoblotting of various key players. In line with the transcriptional analysis we observed significantly reduced levels of NCX1 protein in HCN4tg/wt hearts, a finding that was paralleled by lower levels of SERCA2 and phospholamban (PLN) whole protein content (Fig. 4e, f). Of note, phosphorylation of PLN at its CaMKII-specific Thr-17 site was significantly increased, whereas the rise at its protein kinase A (PKA)-site Ser-16 did not reach statistical significance. Moreover, the Ca2+-sensor protein µ-calpain showed higher levels in HCN4tg/wt hearts, while the L-type calcium channel protein Cav1.2 remained unchanged (Fig. 4e, f). These data document profound alterations in the regulation of calcium handling proteins under the influence of augmented myocardial If.

HCN4 tg/wt cardiomyocytes show altered Ca2+ homeostasis

To determine the influence of increased If on intracellular Ca2+ handling, we measured [Ca2+]i transients in isolated, electrically driven cardiomyocytes of wild type and HCN4tg/wt mice at baseline and after incubation with 3 µM ivabradine (Fig. 5a). Remarkably, we observed a distinctive rise in [Ca2+]i baseline levels and significantly increased systolic [Ca2+]i transients under steady state field stimulation of cardiomyocytes isolated from HCN4tg/wt hearts (Fig. 5a–d). The efficiency of Ca2+ release, however, reflected by the time to peak, was almost unchanged (Fig. 5e). Of note, [Ca2+]i levels, high in HCN4tg/wt cardiomyocytes, dropped to significantly lower levels in ivabradine-treated HCN4tg/wt cardiomyocytes (Fig. 5b), suggesting that abundant HCN4 current mediates diastolic Ca2+ overload and altered Ca2+ homeostasis. Furthermore, the markedly increased slope of Ca2+ uptake (Fig. 5f) and shortened time to half decay (D50) of calcium transients (Fig. 5d) indicate that HCN4 overexpression influences uptake of increased [Ca2+]i to the SR mediated by SERCA. Consistently, If inhibition normalized the slope Ca2+ uptake and [Ca2+]i parameters in cardiomyocytes of transgenic animals (Fig. 5a–f). In addition, Ca2+ load experiments using caffeine 10 mM (Supplementary Fig. 1) showed that the caffeine-induced Ca2+ release peak was significantly higher in HCN4tg/wt cardiomyocytes, indicating that the SR Ca2+ content is increased, which is consistent with the experimental data of higher Ca2+ transients upon electrical stimulation (Fig. 5a–c). Of note, recordings of Ca2+ transients showed abnormal prolongation of diastolic Ca2+ decay (D90 > 2000ms) in 39% of cardiomyocytes isolated from HCN4tg/wt hearts (evaluated separately—please refer to Supplementary Fig. 2), changes that were reduced to wild type level after treatment of HCN4tg/wt cardiomyocytes with ivabradine, underlining that increased If profoundly disorganizes cellular Ca2+ homeostasis.

Fig. 5
figure5

HCN4 overexpression affects intracellular Ca2+ homeostasis. a Representative [Ca2+]i transient traces measured as change in the Fluo-4 fluorescence in electrically driven cardiomyocytes from wild type [baseline (gray) and ivabradine treated (green)] and HCN4tg/wt [baseline (black) and ivabradine treated (magenta)] mice (3 months of age). bf Quantitative analysis reveals a significant change of [Ca2+]i to higher diastolic baseline levels (b), and larger amounts of total cellular Ca2+ movement (reflected by the area under the curve) during the systole in HCN4tg/wt cardiomyocytes (c). Similar time to peak among groups indicates unaffected Ca2+ release from sarcoplasmic reticulum (SR) by ryanodine receptor (RyR) activity (d). Quantification of time to half decay of Ca2+ transients (D50) (e), and slope Ca2+ uptake (f), show that removal of increased baseline [Ca2+]i to the SR, driven by SERCA, is augmented in HCN4tg/wt cardiomyocytes. Changes of HCN4tg/wt cardiomyocytes in Ca2+ homeostasis were mostly reversed by treatment with the If blocker ivabradine (3 µM) underlining that the overexpressed HCN4 current is the pivotal cause for the observed Ca2+ imbalance. Data are expressed as mean ± s.e.m. (wild type: n = 90 cells, HCN4tg/wt: n = 42 cells, iva-treated wild type: n = 48 cells, iva-treated HCN4tg/wt: n = 75 cells derived from six animals/group; *P < 0.05, **P < 0.01, ***P < 0.001 compared to wild type; ANOVA followed by Tukey test). Source data are provided as a Source data file

Reverse mode NCX blockade ameliorates altered Ca2+ cycling

To elucidate the role of NCX in HCN4-mediated perturbation of Ca2+ cycling we recorded [Ca2+]i transients from wild type and HCN4tg/wt cardiomyocytes at baseline and in the presence of the selective NCX inhibitor ORM-1010320.

Interestingly,  NCX inhibition by ORM-10103 (10 µM) reversed the changes in Ca2+ metabolism nearly to wild type levels (Fig. 6a–f). Increased diastolic [Ca2+]i declined remarkably (Fig. 6b) and the amounts of total cellular Ca2+ movement, reflected by the peak area, returned to normal levels (Fig. 6c). Moreover, the increased slope Ca2+ uptake (Fig. 6f) and shortened time to half decay (D50) of calcium transients (Fig. 6d) were restored to levels not significantly different from wild type. Thus, our data demonstrate an important pathophysiological implication of the NCX current in the changed cardiac Ca2+ homeostasis of HCN4tg/wt animals.

Fig. 6
figure6

NCX blockade reverses HCN4-mediated changes of Ca2+ homeostasis. a Representative [Ca2+]i transient traces measured as change in the Fluo-4 fluorescence in electrically driven cardiomyocytes from wild type [baseline (gray) and ORM-10103-treated (orange)] and HCN4tg/wt [baseline (black) and ivabradine-treated (blue)] mice (3 months of age). bf Quantitative analysis reveals changes in Ca2+ homeostasis of HCN4tg/wt cardiomyocytes that were extensively recovered by treatment with ORM-10103. Diastolic [Ca2+]I, markedly increased in HCN4tg/wt cardiomyocytes, was significantly lower after ORM-10103 treatment (TG vs. TG ORM; ***P < 0.001; ANOVA) (b). Similarly, total cellular Ca2+ movement (peak area) (TG vs. TG ORM; ***P < 0.001; ANOVA) (c), time to peak (TG vs. TG ORM; ***P < 0.001; ANOVA) (d) slope Ca2+ uptake ((TG vs. TG ORM; ***P < 0.001; ANOVA) (e), and time to half decay (D50) of calcium transients (TG vs. TG ORM; ***P < 0.001; ANOVA) (f), normalized to wild type levels after treatment of HCN4tg/wt cardiomyocytes with ORM-10103, indicating important implication of dysregulated NCX current in the changed Ca2+ homeostasis of HCN4tg/wt cardiomyocytes. Data are expressed as mean ± s.e.m. (wild type: n = 67 cells, HCN4tg/wt: n = 102 cells, ORM-treated wild type: n = 72 cells, ORM-treated HCN4tg/wt: n = 92 cells derived from six animals/group; *P < 0.05, **P < 0.01, ***P < 0.001 compared to wild type; ANOVA followed by Tukey test). Source data are provided as a Source data file

HCN4tg/wt hearts show increased apoptosis

We then asked whether increased [Ca2+]i would provoke apoptosis in HCN4tg/wt hearts. Using TUNEL assay, we detected significantly higher proportions of nuclei with DNA fragmentation in ventricles of HCN4tg/wt hearts compared to wild type (Fig. 7a, b). In addition, screening of genes associated with apoptosis by qRT-PCR demonstrated a significant rise of the apoptosis effector caspase-3 in transgenic myocardium (Fig. 7c, d; Supplementary Fig. 3). Moreover, we observed higher transcript levels of the Ca2+-sensor protease μ-calpain and the tissue transglutaminase (Fig. 7d), both implicated in myocardial cell death and structural remodeling in association with [Ca2+]i overload21. Further analysis of caspase-3 tissue activity revealed a marked increase of caspase-3-positive cells in HCN4tg/wt ventricles (Fig. 7e, f), pointing to increased apoptotic cell death as an explanation for wall thinning and dilated cardiomyopathy.

Fig. 7
figure7

Assessment of myocardial apoptosis. a Representative TUNEL assay for detection of fragmented nuclear DNA (green) and nuclear counterstaining (red) in cryosections of right ventricles from wild type (left) and HCN4tg/wt (right) mice (2 months of age). b Quantification of TUNEL-positive nuclei in right (RV) and left (LV) ventricular tissue from wild type and HCN4tg/wt mice revealed a significant increase in the number of cells with fragmented nuclear DNA in both ventricles of transgenic animals (n = 6 animals/group; ***P < 0.001; unpaired t-test). c Genes with transcriptional changes > 1.5 fold in HCN4tg/wt compared to wild type hearts (values are normalized to corresponding wild type = 1.0) using the Mouse Apoptosis RT2 Profiler PCR Array (SABioscience). Pronounced transcriptional changes were observed in the apoptosis effector gene caspase-3 (for additional data, please refer to Supplementary Fig. 3). d qRT-PCR transcription analysis of the caspase 3 (Casp3), tissue transglutaminase (tTG), and calpain 1 (Capn1) genes in ventricles of HCN4tg/wt mice normalized to corresponding wild type littermates (wt = 1.0; n = 6 animals/group; ***P < 0.001; unpaired t-test). e Immunohistochemical detection of caspase-3 activity (brown) in representative sections of right ventricular tissue from wild type (left) and HCN4tg/wt (right) mice. f Quantitative analysis shows proportion of cells positive for active caspase-3 in right and left ventricular tissue from wild type and HCN4tg/wt mice (n = 6 animals/group; ***P < 0.001; unpaired t-test). Data are shown as mean ± s.e.m. Source data are provided as a Source data file

Electrophysiological changes in HCN4tg/wt cardiomyocytes

Action potential (AP) recordings of HCN4tg/wt and wild type cardiomyocytes were performed using ruptured whole-cell patch clamp technique (Fig. 8a). In HCN4tg/wt cardiomyocytes RMP was more positive than in wild type cardiomyocytes (wild type: P50 = −61.25 mV, n = 14 vs. HCN4tg/wt: P50 = −54.1 mV, n = 12; p = 0.0013; unpaired t-test) (Fig. 8c), consistent with diastolic depolarisation caused by HCN4-mediated sodium influx. Likewise, the amplitude of overshoot was diminished in transgenic cardiomyocytes (Fig. 8b), pointing to an inactivation of voltage-gated Na+-current at more depolarized RMP. AP properties were evaluated at three different pacing frequencies (0.5, 1, 2 Hz) (Fig. 8d–f). AP duration at 20 (APD20) and 50% (APD50) repolarization were shorter in transgenic cells, with significant changes of APD50 at all pacing frequencies and of APD20 at 0.5 Hz. Evaluation of APD90, by contrast, did not differ significantly between wild type and HCN4tg/wt cardiomyocytes (Fig. 8d–f).

Fig. 8
figure8

Electrophysiological properties of HCN4tg/wt cardiomyocytes. a Representative action potential (AP) traces of wild type (gray) and HCN4tg/wt cardiomyocytes (black). b Quantitative data on AP amplitude of wild type (gray) and HCN4tg/wt (black) cardiomyocytes at different pacing rates (0.5, 1, 2 Hz) showed decreased amplitude of overshoot in cells from transgenic mice. AP amplitudes of HCN4tg/wt cardiomyocytes decreased significantly with higher pacing rates. c HCN4tg/wt cardiomyocytes show depolarized RMP. df AP properties were evaluated at different pacing rates (0.5, 1, 2 Hz). AP duration at 20 (APD20), 50 (APD50), and 90% (APD90) repolarization are depicted. Data are presented as boxplots. Box limits delineate interquartile values, centerlines represent the median and whiskers indicate the range (wild type: n = 20 cells, HCN4tg/wt: n = 17 cells, for RMP: wild type: n = 14 cells, HCN4tg/wt: n = 12 cells derived from n = 5 animals/group; 3 months of age; *P < 0.05, **P < 0.01, ***P < 0.001; unpaired t-test; for evaluation of rate-dependency of AP amplitudes: #P < 0.05; nonparametric ANOVA followed by Dunn’s test). Source data are provided as a Source data file

HCN4tg/wt cardiomyocytes are prone to arrhythmias

Based on the overexpression of depolarizing If and consecutive Ca2+ overload we asked whether HCN4tg/wt cardiomyocytes elicit increased cellular automaticity and/or arrhythmogenesis. Recordings of [Ca2+]i transients and APs (Fig. 9a–g) frequently revealed sustained trains of automaticity in HCN4tg/wt cardiomyocytes (Fig. 9c), while such changes were only sparsely observed in wild type cells. Under steady state field stimulation the [Ca2+]i transients of wild type cardiomyocytes quickly decayed (Fig. 9a), while a subset of HCN4tg/wt cardiomyocytes showed abnormal diastolic [Ca2+]i clearance (Fig. 9b, Supplementary Fig. 2). Correspondingly, transgenic cardiomyocytes were prone to afterdepolarizations (ADs), which resulted in premature APs and arrhythmic firing (Fig. 9e, f). Among all cells recorded, the percentage of cells exhibiting ADs or virtually spontaneous firing, was significantly higher in transgenic (55.5 ± 7.6%; n = 5 hearts; 12–30 cells per heart) than in wild type cardiomyocytes (17.8 ± 3.4%; n = 5 hearts, 22–34 cells per heart; P = 0.0002; ANOVA followed by Tukey test) (Fig. 9g). To delineate the immediate contribution of If to arrhythmogenesis within our model we treated the cells with 3 µM ivabradine (iva). Remarkably, iva treatment diminished spontaneous firing and ADs, and percentage of HCN4tg/wt cardiomyocytes showing arrhythmic behavior after treatment was not different from wild type (Fig. 9g), demonstrating an important contribution of increased If to cellular arrhythmogenicity.

Fig. 9
figure9

HCN4 overexpression leads to increased arrhythmogenicity. ac Representative [Ca2+]i transients measured as change in the Fluo-4 fluorescence in cardiomyocytes from wild type a, and HCN4tg/wt b, c mice (3 months of age). a Normal behavior, exhibited by cardiomyocytes isolated from wild type mice, characterized by lack of automaticity (defined as spontaneous beating rate < 0.2 Hz) and rapid decay of Ca2+ transients under field stimulation. In contrast, cardiomyocytes from HCN4tg/wt mice frequently showed spontaneous pacemaker activity, characterized by periodic firing of [Ca2+]i transients (b), or [Ca2+]i transients with abnormal prolongation of diastolic [Ca2+]i decay (defined as D90 > 2000ms) (c). Field stimulation in a, b is denoted by green arrows. df Recording of spontaneous action potentials (APs) in wild type (d), and HCN4tg/wt (e, f) cardiomyocytes. While most wild type cells lacked relevant automaticity (defined as spontaneous beating rate < 0.2 Hz) (d), a subset of HCN4tg/wt cells showed spontaneous pacemaker activity, with or without afterdepolarizations (ADs). ADs (denoted by dash in e, f) frequently induced spontaneous APs (denoted by arrow in f), leading to arrhythmic firing. f depicts a detail of e. g Quantitative analysis of spontaneous activity of wild type (gray), HCN4tg/wt (black) and ivabradine-treated HCN4tg/wt (magenta) cardiomyocytes indicate a greater proportion of cells with pacemaker activity (Pace) or ADs in HCN4tg/wt cardiomyocytes compared to wild type. Remarkably, spontaneous firing and ADs were diminished after treatment with ivabradine, and percentage of cells showing arrhythmic behavior was not different from wild type thereafter. Data are expressed as mean ± s.e.m. (n = 5 independent experiments [mice] per group, 12–34 cells evaluated per experiment; *P < 0.05, **P < 0.01, ***P < 0.001 compared to wild type; ANOVA followed by Tukey test). h, i Telemetry recording from a HCN4tg/wt mouse showing an episode with premature ventricular captures that occur singular and as triplet. i depicts a detail of h. Source data are provided as a Source data file

Electrophysiological phenotype of HCN4tg/wt mice

To evaluate ECG parameters and to seek for arrhythmias in HCN4tg/wt mice we performed ECG recordings under anesthesia and telemetric recordings in freely roaming animals. Both approaches revealed similar heart rates and conduction parameters among transgenic (HCN4tg/wt) and wild type mice and did not exhibit significant changes of additional ECG parameters (Supplementary Fig. 4, Supplementary Table 1). However, increased numbers of premature ventricular captures and few non-sustained ventricular tachycardias (mostly triplets) were recorded in transgenic but not in wild type animals (Fig. 9h, i), while sustained ventricular tachycardias were not observed. This indicates that HCN4tg/wt mice have a predisposition to ventricular arrhythmogenesis, although high-grade arrhythmias are not part of the phenotype.

Discussion

We here report that augmentation of myocardial If leads to the development of a cardiomyopathy phenotype with biventricular chamber dilation, significantly reduced wall thickness and decreased ejection fraction. To study the myocardial effect of increased If under conditions that minimized its influence on heart rate, we have generated transgenic mice that express human HCN4 (HCN4tg/wt) under control of the murine cTNI promoter. While abundantly expressed in the working myocardium, cTNI is downregulated in the SAN and the conduction system22. This is phenotypically reflected by telemetric recordings revealing similar heart rates and conduction parameters in transgenic and wild type mice (Supplementary Fig. 4, Supplementary Table 1), thus providing the opportunity to selectively study the consequences of HCN4 overexpression in the working myocardium.

There is growing evidence that ion channel disorders not only cause cardiac arrhythmias, but also contribute to structural abnormalities of the heart as well23,24,25,26. We and others reported25,26 that HCN4 loss-of-function mutations are associated with noncompaction cardiomyopathy, pointing to an involvement of HCN4 in ventricular wall maturation at embryonic stages. Accordingly, HCN4 has been identified as primary cell marker for the cardiomyogenic progenitor pool of the first heart field, implicated in the earliest stage of heart formation8,9. During later development and adult stages, HCN4 is downregulated in the healthy myocardium, while abundant expression is restricted to the SAN and the conduction system6. Remarkably, in this context, HCN2 was recently shown to influence developmental brain morphology and function, as well27.

It is well documented that If and the expression of the main ventricular HCN isoforms 2 and 4 are significantly increased in ventricular moycytes of heart failure patients5,11,28. These changes are considered reminiscent of the immature myocytic phenotype, based on the fact that during pathological remodeling several early genes reappear in reverse order compared to embryonic development29. To mimic maladaptive upregulation of HCN4 in our model, the cTNI promoter was used to activate hHCN4 transcription from the intermediate-late phase of fetal development on30, leading to augmented levels in the myocardium throughout postnatal and adult stages, normally characterized by low HCN4 expression6. At physiological RMP of ventricular cardiomyocytes (~−90 mV) patch clamp recordings revealed a two–three-fold higher If density in HCN4tg/wt cardiomyocytes compared to wild type (Fig. 1e, f), reflecting the magnitude of current increase that was found in cardiomyocytes of heart failure patients5. Accordingly, transgenic mice developed myocardial alterations within two months postpartum, supporting a primary maladaptive involvement of increased If. Likewise, we observed a rise of apoptosis and markers of the fetal gene program (Fig. 3a, b) with significantly upregulated cell growth markers e.g. glycogen synthase kinase-3 beta (GSK-3B) and mammalian target of rapamycin (mTOR) (Fig. 4b), indicating cardiac remodeling and activation of compensatory cellular responses. Thus, postnatal myocardium appears susceptible to augmented If levels, and carefully regulated HCN patterning may constitute a prerequisite for the maintenance of structural cardiac integrity. In line, chronic peri- and postnatal treatment of transgenic mice with the If channel blocker ivabradine antagonized the myocardial changes (Fig. 2), underlining that augmented If is key to structural alterations occurring in HCN4tg/wt animals. Noteworthy, the heart rate lowering effect of ivabradine may contribute to protection from adverse remodelling as well.

Given the primary Na+ conductance of HCN4 channels at cardiomyocyte RMP (~−90 mV)31 and the close interrelation of intracellular Na+ and Ca2+ homeostasis32, we asked how increased If might influence Ca2+ cycling. To elucidate the impact of increased If, we measured [Ca2+]i transients in isolated, electrically driven cardiomyocytes in the pre- and absence of ivabradine. Strikingly, we observed a marked rise in [Ca2+]i baseline levels and significantly augmented systolic [Ca2+]i transients in transgenic cardiomyocytes – changes that were fully recovered in the presence of ivabradine. Thus, in the myocardium chronic upregulation of If exerts a diastolic Ca2+ overload and importantly interferes with cellular Ca2+ homeostasis.

As the primary mechanism of Ca2+ efflux in cardiac myocytes is via electrogenic Na+/Ca2+ -exchange (NCX), Ca2+ homeostasis is tightly linked to Na+ regulation32. Under physiological conditions, NCX primarily operates in (forward) Na+ -in/ Ca2+ -out mode, and reduces diastolic [Ca2+]i levels by extruding Ca2+. In pathological states, however, when [Na+]i is increased, NCX exerts ‘reverse mode’ function, moving Ca2+ into the cell32. Notably, [Na+]i is known to rise in a rate dependent fashion32, which exacerbates [Ca2+]i overload at high heart rates. The impact of If on [Na+]i, in relation to membrane potential has been demonstrated in sheep Purkinje fibers by voltage-clamp recordings in early works33,34 after the If mixed Na+ and K+ ionic nature was originally described35. These studies showed that membrane hyperpolarization to below −60 mV significantly increased intracellular Na+ activity, and related this increase to Na+ influx through If, thus providing a direct link between [Na+]i and the size of If. Based on these data, we hypothesized that HCN4 overexpression-mediated accumulation of [Na+]i may raise Ca2+ influx via reverse mode NCX activity (Fig. 10). According to this assumption, instant application of ORM-10103, an agent that effectively inhibits reverse mode NCX20,36, abolished Ca2+ overload, demonstrating the pathophysiological relevance of dysregulated NCX. Likewise, inhibition of increased Na+ influx via HCN4 channels using ivabradine facilitated resetting of the NCX equilibrium towards the ‘forward mode’ and restored [Ca2+]i to wild type levels, similar to ORM-10103. Of note, depolarization of RMP by augmented If may lower the driving force of forward NCX a fortiori, thereby aggravating chronic accumulation of [Ca2+]i in HCN4tg/wt hearts. Based on these data it is reasonable to assume that inhibition of upregulated If in clinical heart failure may attenuate Ca2+ overload of the ventricular myocardium. Synergistically, heart rate lowering decreases [Na+]i32 and therefore shifts the Na+/Ca2+ exchanger equilibrium towards the forward mode, which will alleviate [Ca2+]i overload independently from ventricular If blockade. Thus, besides improved energy supply through heart rate reduction the delineated mechanisms may importantly contribute to positive outcome of patients with heart failure and increased heart rates treated by If blockade13.

Fig. 10
figure10

Proposed pathogenetic processes. Model of how augmented HCN4 expression in the myocardium may contribute to pathological remodeling. HCN4 upregulation mediates diastolic Na+ influx into the cell, leading to a rise of [Na+]i. Ca2+ homeostasis is tightly linked to Na+ regulation via the NCX activity. Under physiological conditions NCX primarily operates in (forward) Na+ -in/ Ca2+ -out mode, reducing diastolic [Ca2+]i. High [Na+]i gives rise to a shift of the NCX equilibrium towards ‘reverse mode’ thereby leading to increased [Ca2+]i. Changed cytoplasmic Ca2+ cycling, in turn, interferes with SR calcium uptake resulting in increased SR Ca2+ stores, driven by augmented phosphorylation of PLN. Sarcoplasmic Ca2+ overload causes afterdepolarizations (ADs) and cardiac arrhythmogenesis, and high diastolic [Ca2+]i activates µ-calpain Ca2+-sensor- and caspase-3-related apoptosis leading to adverse remodeling. Brown arrows indicate regulation of protein expression; green arrows denote changes of ion concentration

We next addressed the effects of increased If and changed Ca2+ homeostasis on cellular electrophysiology. Action potential recordings of isolated HCN4tg/wt cardiomyocytes showed depolarized RMP and reduced amplitude of overshoot in a rate-dependent fashion, consistent with HCN4-mediated diastolic Na+ influx. Furthermore, APD20 and APD50 were shorter compared to WT, while APD90 was similar. This in parts is consistent with previous data obtained from cardiomyocytes overexpressing HCN237, which showed that outward tail current of If shortened APD at membrane potentials more positive than reversal potential (~−35 mV for HCN438), while inward tail current of If prolonged APD at membrane potentials more negative than reversal potential. However, prolongation of APD90 was not observed in our model, most likely due to the repolarizing driving force of the electrogenic ‘reverse mode’ NCX, known to effectively shorten AP duration when [Na+]i is increased39.

Interestingly, we found that myocytes isolated from HCN4tg/wt hearts showed a higher incidence of spontaneous APs than wild type cells, and a subset of cells exerted virtual pacemaker function. The increased automaticity may originate from If augmentation and not from spontaneous Ca2+ cycling-mediated membrane depolarisation, as the NCX equilibrium is shifted toward ‘reverse mode’ leading to an outward, hyperpolarizing current. Moreover, HCN4tg/wt cardiomyocytes were prone to afterdepolarizations resulting in trains of premature APs. Recording of calcium transients showed abnormal diastolic Ca2+ decay in 39% of HCN4tg/wt cells, produced by SR Ca2+ overload, promoting afterdepolarizations and arrhythmic firing40. However, during telemetric recordings HCN4tg/wt animals exhibited no sustained arrhythmias, although higher numbers of PVCs and few nonsustained VTs indicated increased arrhythmogenicity compared to wild type animals. This imbalance between cellular arrhythmogenicity and lack of high-grade arrhythmias in vivo might be explained by source-sink mismatch41 proposing that propagation of ADs originating from single cells (source) is hindered by the rectifying potassium conductance of neighboring myocytes within the myocardial syncytium (sink), thereby protecting the heart from deleterious arrhythmias.

One well-known hallmark of failing heart cells is disturbances in calcium cycling42,43,44. Harmful [Ca2+]i promotes cardiomyocyte death through apoptotic or necrotic pathways43. Previous studies have delineated the association between apoptotic cell-loss and progression of heart failure in animal models and in humans45,46. Moreover, Ca2+ overload induced by persistently activated L-type calcium channels40,43,47 or chronically compromised Ca2+ removal systems47 were shown to induce myocardial cell death and remodeling. Accordingly, the structural changes in our model can be explained by the observed caspase-3-mediated apoptosis. Likewise, we found higher transcript levels of tissue transglutaminase and the Ca2+-sensor protease μ-calpain (Fig. 3d), implicated in the activation of myocardial apoptosis and structural remodeling in association with [Ca2+]i overload21. Basically, upregulation of If in heart failure might be seen as cellular short term mechanism that increases SR calcium load to provide more inotropic support. However, this is at the price of chronic [Ca2+]i accumulation resulting in cell death and disease progression.

In summary, we show that a two–three-fold increase of If in cardiac myocytes, which is comparable to levels observed in human heart failure, affects cardiac structure and promotes cellular arrhythmogenicity in HCN4tg/wt mice. Activation of reverse-mode NCX by increased HCN4-mediated Na+ influx leads to augmented [Ca2+]i and dysregulated Ca2+ homeostasis driving apoptosis and adverse cardiac remodeling. This might have particular implications in disease states associated with increased If, affecting calcium cycling as well as excitation-contraction coupling. Thus, direct cardioprotective mechanisms in addition to improved energy supply at lower heart rates may underlie the beneficial effects of If inhibition in heart failure. Our findings provide insight in previously undescribed cardiac pathomechanisms, bridging a changed electrical state to a structural phenotype, which importantly could influence future treatment strategy of heart failure.

Methods

Generation of transgenic mice

Transgenic mice were generated in a C57Bl/6NCrl background (Charles River Laboratories, Wilmington, MA, USA) by pronuclear injection of an 8.2 kb DNA fragment carrying a 4.3 kb promoter fragment of the murine cTnI gene18,19 joined to the 5′ end of the human HCN4 cDNA48 that was fused to the bovine growth hormone gene poly A signal (Fig. 1a). Tail DNA analysis revealed four different founders that were subsequently bred with C57BL/6 N wild type mice to generate progeny that appeared healthy and fertile.

Care and use of mice

Mixed genotype groups of each gender of no more than five animals were housed in standard mouse cages under specific pathogen-free conditions (12:12-h dark–light cycle, constant temperature, constant humidity and food and water ad libitum). All experiments were carried out in accordance with the Guide for the Care and Use of Laboratory Animals published by the US National Institute of Health (NIH publication number 85–23, revised 1996), and with the European Community guidelines for the use of experimental animals as well as all relevant ethical regulations. Protocols were approved by the local regulatory authority (#35-9185.81/G-20/11 and #35-9185.81/G-226/16 Regierungspräsidium Karlsruhe, Germany). We used male mice for all experiments.

Surface and telemetric ECG recordings

For surface ECG recordings mice were anesthetized with isoflurane vapor titration to maintain the lightest anesthesia possible49. On average, 1.5% vol/vol isoflurane was required to maintain adequate anesthesia. Mice were placed on a heating pad with continuous monitoring of body temperature (via a rectal probe) maintaining at 37 °C. Surface ECGs were recorded using clamp electrodes attached to each limb and to the chest in a midsternal position. The electrodes were connected to a Powerlab System (AD Instruments, Hastings, UK) and ECG recording were performed with a high and low frequency cut off of 1 kHz and 0,1 kHz. ECG recordings were analysed by an investigator blinded to the experimental groups using the Chart 5 software (AD Instruments, Hastings, UK). In addition to average heart rate, at least 30 complexes of each trace were signal averaged and the following parameters were evaluated in lead II: PR-interval, QRS complex duration, and QT-interval. Corrected QT intervals were calculated according to Mitchell et al., 199850, QTc = QT/(RR/100)1/2.

For telemetric ECG recordings, a radiotelemetry transmitter (model EA-F20, Data Sciences International, St. Paul, Minnesota, USA) was surgically inserted into the peritoneal cavity. Mice were anesthetized intraperitoneally with a mixture of ketamine (100 mg/kg) and xylazine (3 mg/kg). The leads were tunnelled under the skin to the recording sites, i.e. one subcutaneous lead placed at the right shoulder and a second subcutaneous lead placed at the lower left thorax. The abdominal skin was closed and mice were kept on a heating pad (37–38 °C) until they were fully recovered from anaesthesia. Before measurement, mice were allowed to recover for 1 week, followed by 24 h recording. ECG signals were converted to digital output and stored on a computer using the Powerlab System (AD Instruments, Hastings, UK), analysis was carried out with the Chart 5 software (AD Instruments, Hastings, UK).

Transthoracic echocardiography

The animals were sedated with low-dose isoflurane (1,5% vol/vol) and placed on a heating pad in supine position. A rectal probe was inserted to monitor the body temperature to maintain it at 37 °C. Chest hair was carefully removed with depilatory cream. Warmed echo gel was placed on the animal’s chest. The Vevo® 2100 device (VisualSonics, Toronto, Canada) with the corresponding transducer MS-400 was used to record the echocardiographies. The investigator was blinded with respect to the treatment group. Mice were shaved, and left ventricular parasternal short-axis views were obtained in M-mode imaging at the papillary muscle level. Three consecutive beats were used for measurements of left ventricular end-diastolic internal diameter (LVEDD) and left ventricular end-systolic internal diameter (LVESD). Fractional shortening (FS) was calculated as FS% = ((LVEDD − LVESD)/LVEDD) × 100.

Transcription analysis

Transcription was assayed by amplification of reverse transcribed total RNA isolated from whole ventricle tissue of wild type and transgenic mice. Hearts were excised, ventricular tissue was carefully dissected and immediately frozen in liquid nitrogen. Total RNA was extracted using TRIzol-Reagent® (Invitrogen, Karlsruhe, Germany) according to the manufacturer’s instructions, followed by reverse transcription (Superscript III, Invitrogen, Karlsruhe, Germany). Quantitative real-time PCR (RT-qPCR) was performed using an ABS 7500 Realtime PCR System (Thermo Fisher, Waltham, MA, USA) according to the manufacturer’s protocol. 96 well optical detection plates (Thermo Fisher, Waltham, MA, USA) were loaded to a total volume of 10 µl per well, consisting of 0.5 µl cDNA, 5 µl TaqMan Fast Universal Master Mix (Thermo Fisher, Waltham, MA, USA), and 6-carboxyfluorescein (FAM)-labeled pre-designed TaqMan primers (TaqMan Gene Expression Assays, Thermo Fisher, Waltham, MA, USA) specific to human and mouse HCN4 transcripts, HCN1, HCN2. qRT-PCR of apoptosis and Ca2+ processing related genes was performed using TaqMan assays for Casp3, tTG, Capn1, RyR2, Serca2a, Pln, Na+/K+-ATPase and NCX1. Ion channel transcripts were examined using TaqMan assays for SCN5A, Cav1.2, Cav1.3, Cav2.1, Cav3.1, Kir2.1, Kv1.4, Kv1.5, Kv4.2, Kv7.1, hERG, and KChip2. Transcripts of myocardial cell growth marker genes and genes of the fetal gene program were determined with TaqMan assays for mTOR, GSK-3B, ANP, Calcineurin and β-MHC. Predesigned primers and probes detecting the housekeeping genes glyceraldehyde 3-phosphate dehydrogenase (GAPDH), hypoxanthine-guanine phosphoribosyltransferase 1 (HPRT1), and beta-actin (ACTB) were applied and normalization was carried out by a modified threshold cycle (CT) relative quantification method using GAPDH (Figs. 1b, 4a, 7d) or all three housekeeping genes (Fig. 4b–e), as published elsewhere51. All TaqMan primers used are listed in Supplementary Table 2. RT-qPCR reactions were performed in triplicate, and data are expressed as an average of triplicates.

Expression of apoptosis related genes was screened with Mouse Apoptosis RT² Profiler PCR Array (PAMM-012A-2, SABiosciences, Frederick, MD, USA) on an ABS 7500 Realtime PCR System and data was analysed using online software “RT2 Profiler PCR Array Data Analysis” (version 3.5) on the manufacturer’s website http://pcrdataanalysis.sabiosciences.com/pcr/arrayanalysis.php.

Protein analysis

Protein immunodetection was performed by sodium dodecyl sulfate (SDS) gel electrophoresis. Tissue sections obtained from indicated mouse left and right ventricle samples were rinsed in phosphate buffered saline (PBS), rapidly frozen in liquid nitrogen and stored at −80 °C. Tissue samples were homogenized (TissueRuptor, QIAGEN, Hilden, Germany) in a radioimmunoprecipitation (RIPA) lysis buffer containing 50 mM Tris-HCl (pH 7.4), 0.5% NP-40, 0.25% sodium deoxycholate, 150 mM NaCl, 1 mM EDTA, 1 mM Na3VO4, 1 mM NaF, and protease inhibitors (Complete; Roche, Indianapolis, IN, USA). The protein concentration was determined using the bicinchoninic acid (BCA) protein assay (Thermo Scientific, Rockford, IL, USA), and equal amounts of protein were separated on SDS polyacrylamide gels. Nitrocellulose membranes were developed by sequential exposure to blocking reagent containing 3% bovine serum albumin and 5% dry milk. Primary antibodies were directed against HCN4 (1:200 diluted in 5% dry milk), NCX1 (1:250), Cav1.2 (1:500), Serca2 (1:1000), Phospholamban (1:500), phosphorylated Phospholamban Thr-17 (1:2000), phosphorylated Phospholamban Ser-16 (1:2000) and Calpain1 (1:2000). Appropriate HRP-conjugated secondary antibodies (anti-rabbit: 1:500, anti-mouse: 1:10,000) were used. Signals were developed using an enhanced chemiluminescence assay (ECL Western Blotting Reagents, GE Healthcare, Buckinghamshire, UK) and quantified with ImageJ 1.41 Software (National Institutes of Health, Bethesda, MD, USA). Protein content was normalized to glyceraldehyde 3-phosphate dehydrogenase (GAPDH) using anti-GAPDH primary antibodies (1:40,000) and corresponding secondary antibodies for digital quantification of optical density. For detailed information on primary and secondary antibodies used please refer to Supplementary Table 3. Western blot images used to compose result panels are available in Supplementary Fig. 5.

Isolation of cardiomyocytes

Cardiomyocytes for intracellular calcium measurements were obtained following the Liao & Jain protocol52. Briefly, the mice received 200 IU heparin i.p. prior to sacrifice. The thoracic chamber was opened and a cannula with perfusion solution was inserted from the atria. The heart was harvested and perfused in the Langendorff system with Perfusion Buffer (in mM: 135 NaCl, 4 KCl, 1 MgCl2, 10 HEPES, 0.33 NaH2PO4, 10 glucose, 20 2,3-butanediones monoxime, 5 taurine, pH7.2 at 37 °C for 5 min), followed by Digestion Buffer treatment (0.3 mg/g body weight collagenase D (Roche, Indianapolis, IN, USA), 0.4 mg/g body weight collagenase B (Roche, Indianapolis, IN, USA), 0.05 mg/g body weight protease XIV (Sigma Aldrich, St. Louis, MO, USA) in 25 ml Perfusion Buffer) until the heart muscle was pale and some signs of extracellular matrix dissociation and for additional 5 min with Perfusion Buffer to stop the dissociation. The cardiomyocytes were mechanically dissociated in Transfer Buffer A in mM: 135 NaCl, 4 KCl, 1 MgCl2, 10 HEPES, 0.33 NaH2PO4, 5.5 glucose, 10 2,3-butanediones monoxime, 5 mg/ml bovine serum albumin (Sigma Aldrich, St. Louis, MO, USA), pH 7.4 at 37 °C) and then plated on ECM-coated (Sigma Aldrich, St. Louis, MO, USA) petri dish (Zell-Kontakt, Nörten-Hardenberg. Germany). The extracellular calcium concentration was increased gradually in three consecutive steps from 0 mM (in Transfer Buffer A) to 0.06, 0.24 and 1.2 mM every 5 min. The cells where then incubated at 37 °C in 5% CO2.

Cellular electrophysiology

If was recorded under voltage-clamp conditions (whole-cell configuration) in isolated mouse ventricular cardiomyocytes at room temperature (21–23 °C), essentially as published53,54. In detail, patch-clamp measurements of mouse ventricular cardiomyocytes were performed in a solution containing (in mM): 137 NaCl, 25 KCl, 8 BaCl, 2 CaCl2, 2 MnCl, 0.2 CdCl, 0.5 4-Aminopyridine, 5 HEPES, 10 Glucose, pH corrected to 7.4 using 1 M NaOH. The patch pipettes pulled from borosilicate glass (GB-150-8P, Science Products, Hofheim Germany) were generated on a DMZ Universal puller (Zeitz Instruments, Munich, Germany) and fire polished to give a final resistance of 2.5–4 MΩ. The pipette solution contained (in mM): 130 K-Aspartate, 5 Na2ATP, 5 CaCl2, 2 MgCl2, 11 EGTA and 10 HEPES, pH corrected to 7.3 using 1 M KOH. Pharmacological agents were added to the bath solution to block L- type calcium currents (10 μM nisoldipine), the slow component of delayed rectifier K+ current (IKs, 10 μM chromanol), the rapid component of delayed rectifier K+ current (IKr, 10 μM E4031), ATP-dependent K+ current (IKATP, 1 μM glibenclamid) and inward rectifier K+ currents (IK1, 50 μM BaCl2). If currents were normalized to cell capacitance which was obtained from the time constant of a current transient evoked by a 5 mV potential step at the beginning of each sweep.

Recordings of cardiac action potentials were carried out in an extracellular solution containing (in mM): 137 NaCl, 5.4 KCl, 1.8 CaCl2, 0.5 MgCl2, 10 HEPES, 5.5 glucose, and a pipiette solution containing (in mM): 120 K-Aspartate, 10 KCl, 5 NaCl, 2 MgCl2, 10 HEPES. For quantification of AP duration and amplitude, cells were held in current-clamp mode and current was injected to achieve a membrane potential of −90 mV. If injected currents exceeded 200pA, recordings were discarded and not included in analysis. APs were evoked by 5 ms suprathreshold depolarizing current injection at 0.5, 1, and 2 Hz frequencies. Quantification of resting membrane potential, and recordings of spontaneous APs and afterdepolarizations were performed without current injection.

If and AP recordings were done with an Axopatch 200B amplifier (Molecular Devices, Sunnyvale, USA), digitized at 20 kHz with a 1401 Power3 Analog/Digital Converter (CED, Cambridge, UK) stored on a hard drive, and analysed off-line with custom MATLAB routines (Mathworks, Natick, USA) software. Recordings with less than 10% leak current were considered for data analysis. No leak subtraction was performed during the experiments. Recordings were discarded if access resistance exceeded 20 MOhm or changed for more than 20% during the recording period.

Recording of calcium transients

The cardiomyocytes were loaded with 10 μM Fluo-4, AM (Molecular Probes, Leiden, The Netherlands) dissolved in Transfer Buffer B (in mM: 137 NaCl, 5.4 KCl, 1.8 CaCl2, 0.5 MgCl2, 10 HEPES, 5.5 glucose, pH 7.4 at 37 °C) for 30 min. For pharmacological treatments ivabradine (Molekula, Munich, Germany; cat. no. 89982651/155974-00-8) or ORM-10103 (Sigma-Aldrich, Germany; cat. no. SML0972) were dissolved in DMSO for stock solution. For working solution, both ivabradine or ORM-10103 were dissolved in Transfer Buffer B at 3 μM or at 10 µM, respectively, and incubated for 10 min prior to the Ca2+ recordings.

[Ca2+]i transients were recorded using an Olympus OSP-3 System fluorescence microscope. Cardiomyocytes were single twitched electrically stimulated at 25 V for 10 ms at constant rate of 0.2 Hz. The fluorescence signal was obtained from cytosolic area and calibrated by a pinhole of 7.5 μm diameter, integrated in the photomultiplier, and A/D converted using PowerLab 4/35 and LabChart V7.0.

Out of 8–10 Ca2+ transients recorded, the least five were analyzed, avoiding the non-physiological Ca2+ transients due to time with no electrical stimulation between cell recordings. Ca2+ transients were eligible for regular analysis when lacking automaticity and showing regular [Ca2+]I clearance under field stimulation at 0.2 Hz. Cells that exhibited pacemaker activity (defined as spontaneous beating rate < 0.2 Hz) or abnormal diastolic [Ca2+]i decay (defined as D90 > 2000ms) were excluded from regular analysis and evaluated in a separate record (please refer to Supplementary Fig. 2).

Calibration was performed at the end of each experiment in freshly loaded cells with Fluo-4, AM to transform voltage values into [Ca2+]i55. Briefly, cells were treated with high Ca2+ solution (in mM: 140 NaCl, 5 KCl, 1.2 KH2PO4, 1.2 MgCl2, 4 CaCl2, 20 HEPES, 0.005 ionomycin, 0.01 CPA, 5 caffeine, 1 ouabaine) to obtain Fmax values followed by application of zero-Ca2+ solution (in mM: 140 LiCl, 5 KCl, 1.2 KH2PO4, 1.2 MgCl2, 20 HEPES, 4 EGTA, 0.005 ionomycin, 0.01 CPA, 5 caffeine, 1 ouabaine) to provide Fmin values. The Ca2+ signal (F) was then converted into [Ca2+]i according to Grynkiewicz et al. 198556.

[Ca2+] = Kd(F-Fmin)/(Fmax-F), with Kd: apparent Ca2+ dissociation constant of the Fluo-4 of 345 nM, according to the manufacturer’s information.

Five biophysical parameters were analyzed: baseline (μM), peak area (area under the curve; μM*s), D50 (duration of the transient at 50% of the peak; ms), time to peak (time required to reach the maximum from the baseline; ms), slope Ca2+ uptake time (time required to return to the base line from the peak to 5% of the baseline; nM/s).

Peri- and postpartal in vivo treatment with ivabradine

For treatment with the If blocker ivabradine (Molekula, Munich, Germany) timed-pregnant HCN4tg/wt and wild type females were subcutaneously implanted with an osmotic mini pump (Alzet, Cupertino, CA, USA) at 18.5 days post-gestation. Ivabradine was delivered at a rate of 1.5 mg/kg/d for 3 weeks to the lactating female, and individual pumps were implanted in the pups from day 20 until 2 months postpartum.

Histochemical analysis and apoptosis assays

Hearts were dissected from transgenic and control mice at the age of 2 months, immediately frozen in isopentane on dry ice and stored at −80 °C. Serial coronal sections of 10 µm were produced for histochemical and immunohistochemical analyses.

For antibody staining, sections were fixed in 10% formaldehyde/PBS pH 7.2 (15 min), washed in PBS (3 × 5 min), permeabilized in 0.5% TritonX/PBS (30 min), blocked in 5% BSA/PBS and exposed for 24–48 h to the primary antibody in blocking solution at 4 °C. Primary antibodies used: rabbit polyclonal anti-HCN4 antibody (1:200; APC-052; Alomone labs, Jerusalem Israel); purified mouse monoclonal anti-caveolin 3 antibody (1:500; 610421; BD Transduction Laboratories, Palo Alto, CA, USA); anti-active caspase-3 (1:10; ab2302; Abcam, Cambridge, UK). Sections were washed in PBS (3 × 5 min) and incubated for 1 h at room temperature with a fluorescent labelled secondary antibody (1:500; MFP555 Goat anti-Rabbit IgG, MFP 488 goat anti-mouse IgG; MoBiTec, Goettingen, Germany) or anti-rabbit HRP-conjugated secondary antibody (Vectashield ABC Kit, Vector Labs, Burlingame, CA, USA). Sections were counterstained for 5 min with propidium iodide (1:500; ab14083; Abcam, Cambridge, UK) at room temperature.

Hematoxylin-eosin and Masson’s trichrome stainings were performed according to standard protocols. In detail, cardiac preparations were fixed in 4% formaldehyde, embedded in paraffin, cut to 6 µm thickness and mounted onto SuperFrost Plus slides (Gerhard Menzel GmbH, Braunschweig, Germany). Sections were then stained with hematoxylin-eosin to analyse cardiac histology or Masson’s trichrome dye to identify interstitial fibrosis. Blue staining following Masson’s trichrome application indicates fibrotic tissue. Cardiac fibrosis was quantified at 10-fold magnification. The extent of fibrosis was defined as the ratio between fibrotic regions and total tissue area [% fibrosis = (area exhibiting fibrosis/total area)*100]. The calculation was based on averaged measurements from 10 sections per animal (right ventricle, five; left ventricle, five). Bright-field images were digitally recorded on Axioplan2 microscope (Zeiss, Oberkochen, Germany) with attached 3CCD camera (Intas, Goettingen, Germany).

TUNEL assay was performed and quantified according to manufacturer’s protocol (DeadEnd™ Fluorometric TUNEL System, Promega). Confocal images of red and green immunofluorescence staining of heart tissue sections were acquired on a Leica confocal laser scanning unit TCS NT, which was coupled to a Leica DM IRB microscope. Acquisition of image series was performed using TCS NT (Leica, Heidelberg, Germany) software. All images were processed in ImageJ version 1.47 (NIH, Bethesda, MD, USA) software using standard quantification methods and standard ImageJ plug-ins.

Electron microscopy

Right and left ventricular wall tissue of HCN4tg/wt and wild type mice was dissected, and prepared for microscopy57. Briefly, cardiac tissue was fixed overnight at 4 °C in a calcium-free buffer (100 mM PIPES, pH 7.4 with 1.25% glutaraldehyde and 2% paraformaldehyde). After several washes with 100 mM PIPES, pH 7.0, samples were incubated for 2 h at room temperature in aqueous 2% osmium tetroxide and 1.5% potassium-hexacyanoferrate solution, washed in water for 3 h and incubated in water with 4% uranyl acetate overnight at 4 °C. Samples were dehydrated as described57 and embedded in Epon medium. Ultra-sections were contrasted in uranyl acetate for up to 20 min and in lead citrate for 5 min. Sections were viewed on Philips EM400T (Philips IS, Eindhoven, The Netherlands) and images were documented on Image Plates and scanned with the Micro Imaging Plate Scanner (DITABIS, Pforzheim, Germany).

Statistical analysis

All experiments and primary analyses were blinded. Statistical analysis was performed using GraphPad Prism 5.0 (GraphPad Prism Inc. La Jolla, CA). Statistical significance and comparisons between samples were analyzed by a two-tailed unpaired Student’s t-test. Comparisons between multiple groups were performed using one-way ANOVA followed by Bonferroni (for calcium recordings), Tukey (for histochemical analysis) or Dunn’s (for action potential amplitudes) post-hoc tests. Differences were considered significant at a level P < 0.05. Data are presented as arithmetic mean ± s.e.m. or median ± maximum/minimum.

Reporting summary

Further information on research design is available in the Nature Research Reporting Summary linked to this article.

Data availability

The data that support the findings of this study are available from the article and the Supplementary Information Files, or from the corresponding author upon reasonable request. A reporting summary for this article is available as a Supplementary Information Files. Source data underlying the Figs. 1b and 1e, 2b–g and 2i–q, 3b and 3d, 4a–e, 5b–f, 6b–f, 7d and 7f, 8b–f, 9g, and Supplementary Figs. 1, 4, and Supplementary Table 1 are provided as a source data file.

Code availability

The MATLAB functions used for data analysis of the cellular electrophysiology experiments (If and AP recordings) have been deposited and are freely available at https://github.com/pgeschwill/NCOMMS-Paper. The code in the repository is associated with a GNU General Public License (GPL 3.0).

References

  1. 1.

    DiFrancesco, D. & Tortora, P. Direct activation of cardiac pacemaker channels by intracellular cyclic AMP. Nature 351, 145–147 (1991).

  2. 2.

    Schulze-Bahr, E. et al. Pacemaker channel dysfunction in a patient with sinus node disease. J. Clin. Invest. 111, 1537–1545 (2003).

  3. 3.

    Schweizer, P. A. et al. cAMP sensitivity of HCN pacemaker channels determines basal heart rate but is not critical for autonomic rate control. Circ. Arrhythmia Electrophysiol. 3, 542–552 (2010).

  4. 4.

    Duhme, N. et al. Altered HCN4 channel C-linker interaction is associated with familial tachycardia-bradycardia syndrome and atrial fibrillation. Eur. Heart J. 34, 2768–2775 (2013).

  5. 5.

    Stillitano, F. et al. Molecular basis of funny current (If) in normal and failing human heart. J. Mol. Cell. Cardiol. 45, 289–299 (2008).

  6. 6.

    Schweizer, P. A. et al. Transcription profiling of HCN-channel isotypes throughout mouse cardiac development. Basic Res. Cardiol. 104, 621–629 (2009).

  7. 7.

    Yasui, K. et al. Ifcurrent and spontaneous activity in mouse embryonic ventricular myocytes. Circ. Res. 88, 536–542 (2001).

  8. 8.

    Liang, X. et al. HCN4 dynamically marks the first heart field and conduction system precursors. Circ. Res. 113, 399–407 (2013).

  9. 9.

    Später, D. et al. A HCN4+ cardiomyogenic progenitor derived from the first heart field and human pluripotent stem cells. Nat. Cell Biol. 15, 1098–1106 (2013).

  10. 10.

    Pitcairn, E. et al. Coordinating heart morphogenesis: a novel role for hyperpolarization-activated cyclic nucleotide-gated (HCN) channels during cardiogenesis in Xenopus laevis. Commun. Integr. Biol. https://doi.org/10.1080/19420889.2017.1309488 (2017).

  11. 11.

    Borlak, J. & Thum, T. Hallmarks of ion channel gene expression in end-stage heart failure. FASEB J. 17, 1592–1608 (2003).

  12. 12.

    Mackiewicz, U. et al. Ivabradine protects against ventricular arrhythmias in acute myocardial infarction in the rat. J. Cell. Physiol. 229, 813–823 (2014).

  13. 13.

    Böhm, M. et al. Heart rate as a risk factor in chronic heart failure (SHIFT): the association between heart rate and outcomes in a randomised placebo-controlled trial. Lancet 376, 886–894 (2010).

  14. 14.

    Bonnet, D., Berger, F., Jokinen, E., Kantor, P. F. & Daubeney, P. E. F. Ivabradine in children with dilated cardiomyopathy and symptomatic chronic heart failure. J. Am. Coll. Cardiol. 70, 1262–1272 (2017).

  15. 15.

    Fox, K. et al. Ivabradine in stable coronary artery disease without clinical heart failure. N. Engl. J. Med. 371, 1091–1099 (2014).

  16. 16.

    Couvreur, N. et al. Chronic heart rate reduction with ivabradine improves systolic function of the reperfused heart through a dual mechanism involving a direct mechanical effect and a long-term increase in FKBP12/12.6 expression. Eur. Heart J. 31, 1529–1537 (2010).

  17. 17.

    Heusch, G. et al. Improvement of regional myocardial blood flow and function and reduction of infarct size with ivabradine: protection beyond heart rate reduction. Eur. Heart J. 29, 2265–2275 (2008).

  18. 18.

    Ausoni, S. et al. Structure and regulation of the mouse cardiac troponin I gene. J. Biol. Chem. 269, 339–346 (1994).

  19. 19.

    Opherk, J. P. et al. Cardiac-specific activation of Cre expression at late fetal development. Biochem. Biophys. Res. Commun. 359, 209–213 (2007).

  20. 20.

    Nagy, N. et al. Selective Na+/Ca2+ exchanger inhibition prevents Ca2+ overload-induced triggered arrhythmias. Br. J. Pharmacol. 171, 5665–5681 (2014).

  21. 21.

    Letavernier, E. et al. The role of calpains in myocardial remodelling and heart failure. Cardiovasc. Res. 96, 38–45 (2012).

  22. 22.

    Brahmajothi, M. V., Steenbergen, C., Strauss, H. C., Campbell, D. L. & Morales, M. J. Expression and distribution of voltage-gated ion channels in ferret sinoatrial node. Physiol. Genom. 42, 131–140 (2010).

  23. 23.

    Olson, T. M. et al. Sodium channel mutations and susceptibility to heart failure and atrial fibrillation. J. Am. Med. Assoc. 293, 447–454 (2005).

  24. 24.

    Ochi, H. et al. HCN4 Gene Polymorphisms are associated with occurrence of tachycardia-induced cardiomyopathy in patients with atrial fibrillation. Circ. Genomic Precis. Med. https://doi.org/10.1161/CIRCGEN.117.001980 (2018).

  25. 25.

    Schweizer, P. A. et al. The symptom complex of familial sinus node dysfunction and myocardial noncompaction is associated with mutations in the HCN4 channel. J. Am. Coll. Cardiol. 64, 757–767 (2014).

  26. 26.

    Milano, A. et al. HCN4 mutations in multiple families with bradycardia and left ventricular noncompaction cardiomyopathy. J. Am. Coll. Cardiol. 64, 745–756 (2014).

  27. 27.

    Pai, V. P. et al. HCN2 Rescues brain defects by enforcing endogenous voltage pre-patterns. Nat. Commun. https://doi.org/10.1038/s41467-018-03334-5 (2018).

  28. 28.

    Cerbai, E. et al. Characterization of the hyperpolarization-activated current, I(f), in ventricular myocytes from human failing heart. Circulation 95, 568–571 (1997).

  29. 29.

    Opthof, T. Embryological development of pacemaker hierarchy and membrane currents related to the function of the adult sinus node: Implications for autonomic modulation of biopacemakers. Med. Biol. Eng. Comput. 45, 119–132 (2007).

  30. 30.

    Gorza, L., Ausoni, S., Merciai, N., Hastings, K. E. M. & Schiaffino, S. Regional differences in troponin I isoform switching during rat heart development. Dev. Biol. 156, 253–264 (1993).

  31. 31.

    DiFrancesco, D. The role of the funny current in pacemaker activity. Circ. Res. 106, 434–446 (2010).

  32. 32.

    Pieske, B. & Houser, S. R. [Na+]i handling in the failing human heart. Cardiovasc. Res. 57, 874–886 (2003).

  33. 33.

    Glitsch, H. G., Pusch, H. & Verdonck, F. The contribution of Na and K ions to the pacemaker current in sheep cardiac Purkinje fibres. Pflügers Arch. Eur. J. Physiol. 406, 464–471 (1986).

  34. 34.

    Boyett, M. R., Hart, G. & Levi, A. J. Factors affecting intracellular sodium during repetitive activity in isolated sheep Purkinje fibres. J. Physiol. 384, 405–429 (1987).

  35. 35.

    DiFrancesco, D. A study of the ionic nature of the pacemaker current in calf Purkinje fibres. J. Physiol. 314, 377–393 (1981).

  36. 36.

    Jost, N. et al. ORM-10103, a novel specific inhibitor of the Na+/Ca2+ exchanger, decreases early and delayed afterdepolarizations in the canine heart. Br. J. Pharmacol. 170, 768–778 (2013).

  37. 37.

    Oshita, K. et al. Ectopic automaticity induced in ventricular myocytes by transgenic overexpression of HCN2. J. Mol. Cell. Cardiol. 80, 81–89 (2015).

  38. 38.

    Ishii, T. M., Takano, M., Xie, L. H., Noma, A. & Ohmori, H. Molecular characterization of the hyperpolarization-activated cation channel in rabbit heart sinoatrial node. J. Biol. Chem. 274, 12835–12839 (1999).

  39. 39.

    Armoundas, A. A., Hobai, I. A., Tomaselli, G. F., Winslow, R. L. & O’Rourke, B. Role of sodium-calcium exchanger in modulating the action potential of ventricular myocytes from normal and failing hearts. Circ. Res. 93, 46–53 (2003).

  40. 40.

    Zhang, X. et al. Persistent increases in Ca2+influx through Cav1.2 shortens action potential and causes Ca2+overload-induced afterdepolarizations and arrhythmias. Basic Res. Cardiol. 111, 4 (2016).

  41. 41.

    Xie, Y., Sato, D., Garfinkel, A., Qu, Z. & Weiss, J. N. So little source, so much sink: Requirements for afterdepolarizations to propagate in tissue. Biophys. J. 99, 1408–1415 (2010).

  42. 42.

    Chien, K. R., Ross, J. & Hoshijima, M. Calcium and heart failure: the cycle game. Nat. Med. 9, 508–509 (2003).

  43. 43.

    Nakayama, H. et al. Ca2+- and mitochondrial-dependent cardiomyocyte necrosis as a primary mediator of heart failure. J. Clin. Invest. 117, 2431–2444 (2007).

  44. 44.

    Eden, M. et al. Myoscape controls cardiac calcium cycling and contractility via regulation of L-type calcium channel surface expression. Nat. Commun. https://doi.org/10.1038/ncomms11835 (2016).

  45. 45.

    Foo, R. S. Y., Mani, K. & Kitsis, R. N. Death begets failure in the heart. J. Clin. Investig. 115, 565–571 (2005).

  46. 46.

    Olivetti, G. et al. Apoptosis in the failing human heart. N. Engl. J. Med. 336, 1131–1141 (1997).

  47. 47.

    Muth, J. N., Bodi, I., Lewis, W., Varadi, G. & Schwartz, A. A Ca2+-dependent transgenic model of cardiac hypertrophy: a role for protein kinase Cα. Circulation 103, 140–147 (2001).

  48. 48.

    Henderson, S. A. et al. Functional adult myocardium in the absence of Na+ -Ca2+ exchange. Circ. Res. 95, 604–611 (2004).

  49. 49.

    Knollmann, B. C. et al. Casq2 deletion causes sarcoplasmic reticulum volume increase, premature Ca2+ release, and catecholaminergic polymorphic ventricular tachycardia. J. Clin. Invest. 116, 2510–2520 (2006).

  50. 50.

    Mitchell, G. F., Jeron, A. & Koren, G. Measurement of heart rate and Q-T interval in the conscious mouse. Am. J. Physiol. 274, H747–H751 (1998).

  51. 51.

    Harrell, M. D., Harbi, S., Hoffman, J. F., Zavadil, J. & Coetzee, W. A. Large-scale analysis of ion channel gene expression in the mouse heart during perinatal development. Physiol. Genom. 28, 273–283 (2006).

  52. 52.

    Liao, R. & Jain, M. Isolation, culture, and functional analysis of adult mouse cardiomyocytes. Methods Mol. Med. 139, 251–262 (2007).

  53. 53.

    Alig, J. et al. Control of heart rate by cAMP sensitivity of HCN. channels Proc. Natl. Acad. Sci. 106, 12189–12194 (2009).

  54. 54.

    Graf, E. M., Heubach, J. F. & Ravens, U. The hyperpolarization-activated current If in ventricular myocytes of non-transgenic and β2-adrenoceptor overexpressing mice. Naunyn. Schmiede. Arch. Pharmacol. 364, 131–139 (2001).

  55. 55.

    Williams, I. A. & Allen, D. G. Intracellular calcium handling in ventricular myocytes from mdx mice. Am. J. Physiol. Circ. Physiol. 292, H846–H855 (2006).

  56. 56.

    Grynkiewicz, G., Poenie, M. & Tsien, R. Y. A new generation of Ca2+ indicators with greatly improved fluorescence properties. J. Biol. Chem. 260, 3440–3450 (1985).

  57. 57.

    Chevessier, F. et al. A new mouse model for the slow-channel congenital myasthenic syndrome induced by the AChR εL221F mutation. Neurobiol. Dis. 45, 851–861 (2012).

Download references

Acknowledgements

We gratefully acknowledge the excellent technical work of Simone Bauer and Ulrike Mersdorf. This work was supported in parts by grants from the Medical Faculty of the University of Heidelberg and the German Cardiac Society (postdoc fellowship and research scholarship to P.Y.), from the German Heart Foundation (Kaltenbach scholarship to T.F.), from the German Cardiac Society and the Hengstberger Foundation (Klaus-Georg and Sigrid Hengstberger Scholarship to D.T.), from the Joachim Siebeneicher Foundation (to D.T.), from the Deutsche Forschungsgemeinschaft (SCHW 1611/1-1 to P.A.S. and TH 1120/8-1 to D.T.), from the Max-Planck-Society (TANDEM project to P.A.S. and M.K.O.) and from the German Centre for Cardiovascular Research (DZHK) (to S.N., C.S., A.P.S., H.E., D.T., H.A.K., P.A.S.). S.N. is recipient of a DZHK doctoral student scholarship. P.A.S. is recipient of the Heidelberg Research Center for Molecular Medicine (HRCMM) Senior Career Fellowship.

Author information

Affiliations

Authors

Contributions

P.Y., M.K.O. and P.A.S. conceived and designed the study and the experiments. P.Y. and M.K.O. generated the transgenic mouse model. P.Y., S.N. and P.A.S. performed the molecular biology experiments. P.Y. and P.A.S. performed the histopathology and immunohistochemistry experiments of mouse hearts. P.G., C.B., C.S., A.P.S. and H.E. performed and analyzed the patch-clamp experiments. M.M., M.W. and R.F. carried out the calcium recordings of isolated cardiomyocytes. S.N., M.K., T.F. and P.A.S. performed the telemetric ECGs of mice and data analysis. S.N. and P.A.S. performed the mouse echocardiography and data analysis. H.A.K. provided administrative support and final approval of the paper. A.D. and D.T. supervised data analysis and provided expertise with paper writing. The paper was written principally by P.A.S.

Corresponding author

Correspondence to Patrick A. Schweizer.

Ethics declarations

Competing interests

The authors declare no competing interests.

Additional information

Peer review information: Nature Communications thanks Dario DiFrancesco, Matteo Mangoni and other anonymous reviewer(s) for their contribution to the peer review of this work. Peer reviewer reports are available.

Publisher’s note: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary information

Source data

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Yampolsky, P., Koenen, M., Mosqueira, M. et al. Augmentation of myocardial If dysregulates calcium homeostasis and causes adverse cardiac remodeling. Nat Commun 10, 3295 (2019). https://doi.org/10.1038/s41467-019-11261-2

Download citation

Further reading

Comments

By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.